Millions of American Women Have a Condition Doctors Rarely Test For
10 min read
This article was originally published by Undark Magazine.
About three years ago, Soumya Rangarajan struggled day after day with exhaustion, headaches, and heart palpitations. As a frontline hospital doctor during the coronavirus pandemic, she first attributed her symptoms to the demands of an unprecedented health-care crisis.
But a social-media post got Rangarajan thinking about the possibility that she might actually be the victim of something more mundane: an iron deficiency. She requested a blood test from her doctor, and the results determined she had anemia, a condition caused by lower-than-normal levels of iron in the blood.
It was the first step toward relief, recalls Rangarajan, who is a geriatrician at the University of Michigan. Her symptoms, she adds, had made it so she “had difficulty getting through a full week at work.”
Although estimates vary, some research suggests that about a third of women of reproductive age in the United States may not get enough iron, which helps support various functions in the body. But despite the high prevalence of iron deficiency, it isn’t routinely screened for during annual health examinations.
“Women are only tested if they present to a health-care provider and are having symptoms,” says Angela Weyand, a pediatric hematologist at the University of Michigan. And although the American College of Obstetricians and Gynecologists does recommend screening pregnant people for anemia—which can result in the body having too few healthy red blood cells—providers likely miss many patients who are iron-deficient but not anemic, Weyand says, because it requires other testing.
Meanwhile, the U.S. Preventive Services Task Force, which makes recommendations about clinical preventive services, recently reviewed studies on iron-deficiency screening and supplementation practices for asymptomatic pregnant people. On August 20, it concluded that there was insufficient evidence to recommend routine screenings, because the existing data did not clearly indicate whether screening for iron deficiency absent symptoms made a significant difference.
But some clinicians disagree. And the ambiguous nature of iron-deficiency signs—which can include lethargy, irritability, and pale skin—coupled with the lack of specific recommendations for nonpregnant women means the condition can be easily overlooked, Weyand says. Doctors might simply suggest that tired women should get more sleep, for example.
Margaret Ragni, who recently retired as a hematologist, recalls that female patients fairly commonly came in with symptoms pointing to low iron levels.
“Iron deficiency is associated with a really poor quality of life,” says Ragni, also an emeritus professor of clinical translation research at the University of Pittsburgh. Annual screenings could go a long way toward offering relief: “These poor women really could feel so much better.”
Iron is a vital component of a protein in red blood cells, hemoglobin, which helps carry oxygen to every part of the body. The mineral is also essential for a number of various other cellular functions, including energy production and maintenance of healthy skin, hair, and nails.
The body can store some iron temporarily in the form of a protein called ferritin, but if the levels dip too low for too long, so does the hemoglobin in red blood cells, resulting in anemia. But even without anemia, low iron levels can cause health problems.
In addition to physical symptoms such as lightheadedness and shortness of breath, women with iron deficiency can struggle with anxiety, depression, and restless legs syndrome, Weyand says. Iron deficiency has also been associated with heart failure, hearing loss, and pica—a craving for substances such as ice, dirt, or clay. “People can have hair loss and nail changes,” she says. “They can have decreased cognitive abilities, which is hard to tease out.”
Many physicians “think of iron deficiency in terms of anemia, but that’s the last manifestation of iron deficiency,” Weyand says. “And we know iron is important for a lot of other things.”
The need for iron especially increases during pregnancy, when people are even more vulnerable to anemia, says Michael Georgieff, a pediatrics professor and co-director of the Masonic Institute for the Developing Brain at the University of Minnesota.
But even when a growing fetus demands more iron intake, pregnant patients may not always be screened for iron deficiency. Georgieff recalled that three years ago, he accompanied his pregnant daughter to see her obstetrician and was surprised to learn that her blood wouldn’t be tested for iron deficiency. When he asked why, he was told that only people who reported symptoms were screened.
“Pregnancy itself is essentially an iron-deficient state,” he says. “In other words, the iron requirements of the mom go up dramatically during pregnancy. And if you don’t screen and supplement, it’s very hard to keep up with her iron status.”
Moreover, when pregnant women develop anemia, they likely will have difficult pregnancies, Georgieff says. The consequences can be “more premature births, more low-birth-weight babies. And those babies are not loaded with enough iron, then, for their needs once they are out.”
During pregnancy, the fetus depends on the maternal iron it gets through the placenta, a temporary organ that also provides nourishment and oxygen. If mothers-to-be have low iron or anemia, it can affect newborn development. Some research suggests that if a woman is iron-deficient when she conceives, or during the first trimester, the child may be at higher risk of a future cognitive impairment.
Anemia early on in pregnancy has long been associated with greater risks of delivering premature babies and possible health conditions for mothers, including preeclampsia. But research suggests that even though the condition can have an impact, it’s still unclear whether iron therapy can adequately reduce the risks. And although many experts agree on the need to treat iron-deficiency anemia, there’s no consensus for treatment of iron depletion not associated with anemia.
Ragni says she made it a point to screen patients for depleted iron to catch iron deficiency before anemia develops. But, she adds, recommendations from institutions such as the U.S. Preventive Services Task Force could prompt more American providers to screen. “For women of reproductive age, whether they’re pregnant or not, it’s really critical to test,” Ragni says. “There should be a standard test for these women.”
A major reason for iron deficiency among nonpregnant women is menstrual bleeding, which is why they’re at comparatively higher risk to men. “Women who have excess blood loss are really at an even higher risk,” Ragni says.
The World Health Organization has estimated that, globally, about 30 percent of women between 15 and 49 years old were anemic in 2019.
And some research suggests that vulnerability to iron deficiency can start at a young age. A 2023 study that Weyand co-authored found that the overall prevalence of iron deficiency among women and girls aged 12 to 21 was more than 38 percent; the prevalence of iron-deficiency anemia was about 6 percent. But that rate changes depending on how iron deficiency is defined.
To determine someone’s iron count, labs look at the concentration of ferritin—the protein that stores iron—in their blood. A common threshold established by the WHO says that anything below 15 micrograms of ferritin per liter of blood is iron-deficient. When Weyand’s team used that threshold, they found that 17 percent of participants were iron-deficient. But when they upped the threshold cutoff to 50 micrograms per liter, the number of iron-deficient participants climbed to nearly 78 percent.
Weyand says the results reflect a need for a higher threshold for women of 50 micrograms per liter for ferritin, because some studies suggest that such a cutoff is consistent with iron deficiency. But there’s no consensus about which cutoff is most accurate to indicate iron deficiency; other research, for example, suggests 30 micrograms per liter is an effective cutoff.
Still, researchers like Weyand call for raising the thresholds to avoid false negative results that would keep people with iron deficiency from being diagnosed and treated. This would, she says, “capture patients who otherwise have been ignored and dismissed or told their symptoms were due to some other issue.”
Weyand became an advocate for people who struggle with iron deficiency after seeing many patients with heavy menstrual bleeding and iron depletion. Most had never been screened or received treatment.
Although iron deficiency in nonpregnant women is primarily associated with menstruation, other risk factors include iron-poor diets and gut disorders, like celiac disease, that cause poor iron absorption. There’s also evidence that women in poverty are at higher risk of iron deficiency because of food insecurity.
Iron deficiency is an easily treatable condition with iron supplements, Weyand says, but “it’s difficult to treat if you don’t know it’s there.”
After her anemia diagnosis, Rangarajan says, she started taking iron tablets daily, but cut back to three times a week for a few months. She found it hard to cope with the supplements’ side effects, which included stomach cramps, nausea, and constipation.
Rangarajan, now 39, eventually urged her primary-care physician to switch her treatment to intravenous iron supplements. After waiting for several months for approval from her medical insurance, Rangajaran got her first infusions in March. The effect took hold within a week. “The headaches were gone; I didn’t notice any palpitations anymore; my energy levels were up,” she says. “So I definitely noticed a significant difference.”
In fact, one of Weyand’s social-media posts is what prompted Rangarajan to get tested for iron deficiency. Weyand often advocates on her online platforms for attention to iron deficiency and hears from many working women about how diagnosis and treatment of iron deficiency had finally ended “horrible” symptoms that sometimes lasted for decades. Doctors are greatly “undertreating iron deficiency currently,” she says.
After menopause, women need much less iron. The recommended intake for the nutrient drops from a daily average iron intake of about 18 milligrams to about eight milligrams. “What’s hard is that the vast majority of these women aren’t diagnosed while they are menstruating, and so, going into menopause, they probably are low,” Weyand says. “And depending on how low they are, it would dictate how long it would take them to replenish once they stop bleeding.”
Iron deficiency is rare in men—estimated to affect about 2 percent of U.S. men—but when it develops, similarly to menopausal women, it can signal an underlying condition such as an ulcer or cancer. As Weyand puts it: “It’s more of a red flag in terms of figuring out why they’re iron-deficient.”
Iron deficiency is a significant health problem not just in the United States but worldwide. The International Federation of Gynecology and Obstetrics, which promotes women’s health globally, issued recommendations in 2023 to regularly screen all menstruating women and girls for iron deficiency—ideally, throughout their life.
Weyand says she hopes the recommendations and more research into the health benefits of iron-deficiency screening will help increase awareness among American health providers of the need to screen for iron deficiency. “We screen for lots of things that are less common than this,” she says.
Meanwhile, the findings of the U.S. Preventive Services Task Force didn’t sit well with Georgieff, whose research at the University of Minnesota focuses on the effect of iron on fetal brain development. Health-care providers are not generally screening for iron, he says, and the task force’s decision does not promote change.
Although the task force acknowledged that pregnant people are at risk of developing iron deficiency and iron-deficiency anemia, it concluded that there’s a lack of evidence on the effectiveness of screening pregnant people who show no signs or symptoms.
The latest task-force review included more than a dozen studies on the impact of routine iron supplementation on pregnant people. They found that, compared with placebo, prenatal iron supplementation resulted in no significant differences in maternal quality of life or conditions such as gestational diabetes or maternal hemorrhage.
Virtually none of the studies examined the benefits or harms of screening for iron deficiency and iron-deficiency anemia during pregnancy. The volunteer panel issued an “I statement,” which means the evidence is insufficient—perhaps because it’s not available, poor, or conflicting. In 2015, the group also reached a similar conclusion after assessing existing evidence at that time regarding iron-deficiency anemia in pregnant people.
More research is needed to effectively assess the potential health impact of iron screening and supplementation for asymptomatic pregnant people, says Esa Davis, a task-force member and associate vice president for community health at the University of Maryland School of Medicine.
“We need studies that are done to show us the benefit or the harm of screening for both iron deficiency and iron-deficiency anemia,” she says, “and studies that show us the benefits and the harm of supplementing in this group as well.”
Weyand says she hopes ongoing research on iron deficiency in women will boost the chances that the task force and other groups will take up the issue of regular screening again—both for pregnant and nonpregnant people. “Hopefully, it will lead to meaningful change,” she says.
Having felt the debilitating effects of iron deficiency and anemia, Rangarajan says she knows firsthand how crucial screening can be for diagnosis and effective treatment. “I feel like my energy is so much better,” she says. “I feel like my performance at work has improved tremendously with IV iron because I don’t feel so fatigued even at a very busy stretch. I feel like I have this strength that I had when I was in my 20s.”
